About US
Contact us
-
Sanofi-Aventis Q4 Sales UpFrench drug manufacturer Sanofi-Aventis reported sales of €7.39bn in the fourth quarter of 2010, up 0.5% on last year's figures. Exchange rate movements had a favourable effect, amounting to 6.4%, w2011/2/12
-
FDA Approves First Drug to Reduce Preterm Delivery RiskThe US Food and Drug Administration (FDA) has approved the Makena (hydroxyprogesterone caproate) injection, which can reduce the risk of preterm delivery. The drug is intended for use in pregnant wo2011/2/11
-
GlaxoSmithKline Faces Legal Action Over Parkinson's DrugGlaxoSmithKline could face legal action after its Requip drug, taken by Parkinson's disease sufferers, was said to cause gambling addiction. A man from the UK is the latest patient to complain about2011/2/11
-
Global Health Consortium to support development of vaccines to control dengue feverGlobal Health Consortium will raise the profile of dengue and promote prevention through vaccinationThe International Vaccine Institute (IVI) today announced the launch of the Dengue Vaccine Initiativ2011/2/11
-
Three government agencies jointly issue notice on strengthening the supervision of prepared slices of Chinese crude drugsTo further intensify the supervision to the prepared slices of Chinese crude drugs and promote the sound development of traditional Chinese medicine, the State Food and Drug Administration, the Minist2011/2/9
-
FDA Grants Orphan Drug Designation to Bayer's Investigational Compound Regorafenib for the Treatment of Gastrointestinal Stromal TumorsWAYNE, N.J., Feb. 4, 2011 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc. announced today that its investigational compound regorafenib (BAY 73-4506) has been granted orphan drug status2011/2/9
-
China's Ministry of Commerce Grants Clearance for Merger of BMP Sunstone and Sanofi-aventis SubsidiaryNEW YORK, Jan. 27, 2011 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone Corporation (Nasdaq: BJGP) announced today that China's Ministry of Commerce granted clearance for the transaction in which sanofi-a2011/1/28
-
FDA issues Complete Response letter for Avodart sNDA for reduction of prostate cancer riskGlaxoSmithKline (GSK) today announced that the Company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for the supplemental New Drug Application (sNDA) for Avo2011/1/28
-
Merck Canada Invests $5 Million in Quebec Consortium for Drug Discovery to Support Biopharmaceutical ResearchMONTREAL, Jan. 26 /CNW Telbec/ - Merck Canada has renewed its partnership with the Quebec Consortium for Drug Discovery (CQDM) by investing a further $5 million over five years in the organization so2011/1/27
-
GlaxoSmithKline Begins Melanoma Drug ResearchGlaxoSmithKline has commenced Phase III studies of two investigational agents for patients with advanced melanoma. The studies will test the efficacy and safety of GSK2118436 and GSK1120212 to dete2011/1/26